Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics.
Introduction
CV Sciences (OTCQB:CVSI) reported 2019 Q3 results that reflected an increasingly competitive CBD market. We recently voiced our concern that CVSI is not making the necessary investments to maintain its early advantage. We believe CVSI will continue to face increasing pressure from new entrants unless management takes bold action.
Note: All amounts in US$
2019 Q3 Review
CVSI reported 2019 Q3 results that saw revenue falling 25% from last quarter.